| bombesin and nutrients additively stimulate GIP release from GIP/Ins cells. | Bombesin and nutrients independently and additively regulate hormone release from GIP/Ins cells.
Li L, Wice BM. | 01/21/2010 |
| GIP is rapidly degraded into inactive metabolites by the enzyme dipeptidyl-peptidase-IV. (review) | Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes.
Gautier JF, Fetita S, Sobngwi E, Salaün-Martin C. | 01/21/2010 |
| GIP augments glucose-stimulated insulin secretion and acts as an endogenous inhibitor of gastric acid secretion--REVIEW | Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide.
Meier JJ, Nauck MA. | 01/21/2010 |
| Results describe the solution structure of GIP(1-30)amide, the major biologically active fragment of glucose-dependent insulinotropic polypeptide. | NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amide.
Alaña I, Hewage CM, Malthouse JP, Parker JC, Gault VA, O'Harte FP. | 01/21/2010 |
| Elevated plasma GIP levels are correlated with hyperinsulinemia in the impaired glucose-tolerant state, whereas type 2 diabetes is associated with a failure to secrete adequate amounts of GIP. | Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.
Theodorakis MJ, Carlson O, Muller DC, Egan JM. | 01/21/2010 |
| activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway | Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway.
Ehses JA, Pelech SL, Pederson RA, McIntosh CH. | 01/21/2010 |